SCHEMBL31542263

SCHEMBL31542263

CN1CCNc2cc(-c3cnn(C)c3)ccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AXL P30530 2/20 0.41
LOXL2 Q9Y4K0 1/20 0.41
ACVR1 Q04771 1/20 0.41
OTUD7B Q6GQQ9 1/20 0.40
PIK3CD O00329 1/20 0.40
PIK3CA P42336 1/20 0.40
PIK3CB P42338 1/20 0.40
PI4KA P42356 1/20 0.40
PIK3CG P48736 1/20 0.40
PI4KB Q9UBF8 1/20 0.40
CCNC P24863 1/20 0.39
CDK8 P49336 1/20 0.39
PRMT5 O14744 2/20 0.39
WDR77 Q9BQA1 2/20 0.39
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
CREBBP Q92793 1/20 0.39
BRD4 O60885 1/20 0.38
RET P07949 1/20 0.38
EPHX2 P34913 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17809644 1.00 AXL (0.41) AXLLOXL2ACVR1OTUD7BPIK3CD
SCHEMBL29471186 0.89 AXL (0.44) AXLLOXL2ACVR1OTUD7BPIK3CD
SCHEMBL20571990 0.89 AXL (0.44) AXLLOXL2ACVR1OTUD7BPIK3CD
SCHEMBL19369146 0.84 LOXL2 (0.41) AXLLOXL2ACVR1OTUD7BPIK3CD
SCHEMBL17806370 0.84 ACVR1 (0.41) AXLLOXL2ACVR1OTUD7BPIK3CD
SCHEMBL17795291 0.80 KDM4E (0.51) AXLLOXL2ACVR1PIK3CDPIK3CA
SCHEMBL17864434 0.79 PIM1 (0.39) CYP11B1CYP11B2BRD4LRRK2PIM1
SCHEMBL24317104 0.77 DYRK1A (0.40) GSK3BDYRK1ALRRK2PIM1
SCHEMBL17785716 0.77 KDM1A (0.48) AXLLOXL2ACVR1OTUD7BPIK3CD
SCHEMBL26552720 0.76 PIM1 (0.49) PIM1PIM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025062330-A1 HETEROCYCLIC COMPOUNDS AS CBP SELECTIVE DEGRADERS AURIGENE ONCOLOGY LIMITED (IN) 2025-03-27 WO disclosed